US Stock MarketDetailed Quotes

Cytek Biosciences (CTKB)

Watchlist
  • 4.460
  • +0.060+1.36%
Close Apr 27 16:00 ET
  • 4.850
  • +0.390+8.74%
Pre 04:01 ET
573.33MMarket Cap-8.58P/E (TTM)

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Cytek Biosciences (CTKB) Revenue Breakdown Overview

By Business/Source

Currency:USD
2025/FY
Stock NameRevenueRatio
Product144.23M71.58%
Service57.26M28.42%

By Country/Region

Currency:USD
2025/FY
Stock NameRevenueRatio
United States95.25M47.27%
Europe, the Middle East and Africa (EMEA)55.88M27.73%
Asia Pacific (APAC)41.08M20.39%
Other9.28M4.61%
Market Insights
No. Symbol 20D % Chg
Sample Name
Sample Code
 +20.72%
Sample Name
Sample Code
 +8.47%
Sample Name
Sample Code
 +7.98%
4
VanEck Oil Services ETF
OIH
+5.58%
5
ProShares Ultra Bloomberg Crude Oil ETF
UCO
+4.68%
View More
China Concept Stocks
No. Symbol 5D % Chg
Sample Name
Sample Code
 +10.58%
Sample Name
Sample Code
 +6.89%
Sample Name
Sample Code
 +5.36%
4
Chagee Holdings
CHA
+3.18%
5
Qifu Technology
QFIN
+0.60%
View More
Middle East conflict spreads to the stock market! How should investors respond?
In the early hours of the 27th local time, Iran conveyed a three-phase negotiation plan to the US side, indicating that talks could resume i Show More
Long-term answers | Your account on the left shrinks, while your right hand is chased by the times — Be the person that no bombardment can ever wipe out.
Hormuz, Term Structure and USO: Navigating the Energy Storm

- No more -